A Test-and-Not-Treat Strategy for Onchocerciasis Elimination in Loa loa–coendemic Areas: Cost Analysis of a Pilot in the Soa Health District, Cameroon
Author(s) -
Edeltraud J. Lenk,
Henri Claude Moungui,
Michel Boussinesq,
Joseph Kamgno,
Hugues C. Nana-Djeunga,
Christopher Fitzpatrick,
Anne-Claire M M Peultier,
Amy D. Klion,
Daniel A. Fletcher,
Thomas B. Nutman,
Sébastien D. S. Pion,
Yannick Niamsi-Emalio,
Ken Redekop,
Johan L. Severens,
Wilma A. Stolk
Publication year - 2019
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciz461
Subject(s) - loa loa , onchocerciasis , medicine , test (biology) , environmental health , filariasis , immunology , helminths , ecology , biology
Severe adverse events after treatment with ivermectin in individuals with high levels of Loa loa microfilariae in the blood preclude onchocerciasis elimination through community-directed treatment with ivermectin (CDTI) in Central Africa. We measured the cost of a community-based pilot using a test-and-not-treat (TaNT) strategy in the Soa health district in Cameroon.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom